跳至主要内容
临床试验/NCT03539913
NCT03539913已完成4 期

Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children

Biocodex8 个研究点 分布在 1 个国家目标入组 317 人开始时间: 2017年6月19日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
Biocodex
入组人数
317
试验地点
8
主要终点
Time frame in hours up to the time of the last liquid or loose stool as recorded in the stool diary

研究概览

简要总结

  • Primary Objective:

o To assess the efficacy of the probiotics in reducing the duration of diarrhea in children suffering from acute gastroenteritis.

  • Secondary Objectives:

  • To assess the efficacy of the probiotics in improving the frequency and consistency of stools.

  • To assess the efficacy of the probiotics in avoiding recurrence of diarrhea.

  • To assess the efficacy of the probiotics on the disease severity.

  • To assess the safety and tolerability of the studied probiotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

盲法说明

Allocation-blinded study

入排标准

年龄范围
6 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children of both gender aged between 6 months and 5 years
  • Presenting with acute diarrhea (3 or more loose or liquid stools in a 24-hour period) since at least the last 24h but less than 5 days
  • Signed informed consent of the legal representatives obtained before any study procedure
  • Parents able to fulfill in the stool diary according to the physician's opinion.

排除标准

  • Unable to take medication and fluids by mouth
  • More than 50% breastfeeding
  • Severe malnutrition, defined by a ratio weight/height at/or below -3SD
  • Severe dehydration, defined by a need of IV rehydration
  • Chronic underlying disease, including but not limited to severe gastrointestinal disorder, immunocompromised condition or systemic infection
  • Use of prohibited treatments
  • Contra-indications to the studied probiotics

研究组 & 干预措施

Saccharomyces boulardii

Active Comparator

Floratil, 250 mg sachets, twice daily (1 in the morning and 1 in the evening) during 5 consecutive days.

干预措施: Probiotic : Saccharomyces boulardii (Biological)

Bacillus clausii

Active Comparator

Enterogermina, 5 ml vials, twice daily (1 in the morning and 1 in the evening) during 5 consecutive days.

干预措施: Probiotic : Bacillus clausii (Biological)

结局指标

主要结局

Time frame in hours up to the time of the last liquid or loose stool as recorded in the stool diary

时间窗: 5 days

Time frame in hours up to the time of the last liquid or loose stoll (defined as type 6 or 7 on Bristol Stool Scale) followed by the first 24-hour period with stool consistency improvement (no liquid or loose stool), i.e. cessation of diarrhea as recorded by the parents in the stool diary.

次要结局

未报告次要终点

研究者

发起方
Biocodex
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验